299 related articles for article (PubMed ID: 34831366)
1. Autophagy in α-Synucleinopathies-An Overstrained System.
Fellner L; Gabassi E; Haybaeck J; Edenhofer F
Cells; 2021 Nov; 10(11):. PubMed ID: 34831366
[TBL] [Abstract][Full Text] [Related]
2. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
[TBL] [Abstract][Full Text] [Related]
3. In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons.
Fouka M; Mavroeidi P; Tsaka G; Xilouri M
Front Cell Dev Biol; 2020; 8():559791. PubMed ID: 33015057
[TBL] [Abstract][Full Text] [Related]
4. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies.
Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI
Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615
[TBL] [Abstract][Full Text] [Related]
5. The 'α-synucleinopathy syndicate': multiple system atrophy and Parkinson's disease.
Sian-Hulsmann J; Riederer P
J Neural Transm (Vienna); 2024 Jun; 131(6):585-595. PubMed ID: 37227594
[TBL] [Abstract][Full Text] [Related]
6. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.
Creed RB; Memon AA; Komaragiri SP; Barodia SK; Goldberg MS
Acta Neuropathol Commun; 2022 May; 10(1):78. PubMed ID: 35606853
[TBL] [Abstract][Full Text] [Related]
7. α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.
Wong YC; Krainc D
Nat Med; 2017 Feb; 23(2):1-13. PubMed ID: 28170377
[TBL] [Abstract][Full Text] [Related]
8. Structures of α-synuclein filaments from multiple system atrophy.
Schweighauser M; Shi Y; Tarutani A; Kametani F; Murzin AG; Ghetti B; Matsubara T; Tomita T; Ando T; Hasegawa K; Murayama S; Yoshida M; Hasegawa M; Scheres SHW; Goedert M
Nature; 2020 Sep; 585(7825):464-469. PubMed ID: 32461689
[TBL] [Abstract][Full Text] [Related]
9. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N
Nat Med; 2023 Jun; 29(6):1448-1455. PubMed ID: 37248302
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb.
Rey NL; Bousset L; George S; Madaj Z; Meyerdirk L; Schulz E; Steiner JA; Melki R; Brundin P
Acta Neuropathol Commun; 2019 Dec; 7(1):221. PubMed ID: 31888771
[TBL] [Abstract][Full Text] [Related]
11. Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies.
Rcom-H'cheo-Gauthier AN; Osborne SL; Meedeniya AC; Pountney DL
Front Neurosci; 2016; 10():570. PubMed ID: 28066161
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Hoppe SO; Uzunoğlu G; Nussbaum-Krammer C
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34201558
[TBL] [Abstract][Full Text] [Related]
13. Sleep-controlling neurons are sensitive and vulnerable to multiple forms of α-synuclein: implications for the early appearance of sleeping disorders in α-synucleinopathies.
Dos Santos AB; Skaanning LK; Thaneshwaran S; Mikkelsen E; Romero-Leguizamón CR; Skamris T; Kristensen MP; Langkilde AE; Kohlmeier KA
Cell Mol Life Sci; 2022 Jul; 79(8):450. PubMed ID: 35882665
[TBL] [Abstract][Full Text] [Related]
14. Retrograde Axonal Autophagy and Endocytic Pathways Are Parallel and Separate in Neurons.
Kulkarni VV; Stempel MH; Anand A; Sidibe DK; Maday S
J Neurosci; 2022 Nov; 42(45):8524-8541. PubMed ID: 36167783
[TBL] [Abstract][Full Text] [Related]
15. Nuclear aggregates of NONO/SFPQ and A-to-I-edited RNA in Parkinson's disease and dementia with Lewy bodies.
Belur NR; Bustos BI; Lubbe SJ; Mazzulli JR
Neuron; 2024 May; ():. PubMed ID: 38761794
[TBL] [Abstract][Full Text] [Related]
16. Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies.
Bouvier-Müller A; Fourmy D; Fenyi A; Bousset L; Melki R; Ducongé F
Nucleic Acids Res; 2024 Jun; ():. PubMed ID: 38917326
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Fractionation of Human α-Synuclein in a
Imomnazarov K; Lopez-Scarim J; Bagheri I; Joers V; Tansey MG; Martín-Peña A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612454
[TBL] [Abstract][Full Text] [Related]
18. Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson's disease.
Yan M; Xiong M; Dai L; Zhang X; Zha Y; Deng X; Yu Z; Zhang Z
NPJ Parkinsons Dis; 2022 Jan; 8(1):1. PubMed ID: 35013321
[TBL] [Abstract][Full Text] [Related]
19. The mechanistic interaction, aggregation and neurotoxicity of α-synuclein after interaction with glycyrrhizic acid: Modulation of synucleinopathies.
Zhang L; Zhang N; Pang C
Int J Biol Macromol; 2024 May; 267(Pt 2):131423. PubMed ID: 38583832
[TBL] [Abstract][Full Text] [Related]
20. Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy.
Böing C; Di Fabrizio M; Burger D; Bol JGJM; Huisman E; Rozemuller AJM; van de Berg WDJ; Stahlberg H; Lewis AJ
Brain; 2024 May; ():. PubMed ID: 38696728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
